Emergen Research

Growing prevalence of chromosome syndrome in babies is one of the significant factors influencing the market growth.

SURREY, BRITISH COLUMBIA, CANADA , April 24, 2022 /EINPresswire.com/ -- prenatal testing and newborn screening market has recently added a report Forecast to 2027 to its repository, which comprises of data relating to the market size, share, value, and volume, production processes, revenue generation, the regional analysis of the business vertical, along with the outcomes of analytical tools including, SWOT analysis and Porter’s Five Forces analysis. The report highlights the growth opportunities and challenges that industry players might encounter in the forecast years, along with an elaborate competitive landscape and expansion strategies adopted by the companies functioning in the Keyword Market.

Growing prevalence of chromosome syndrome in babies is one of the significant factors influencing the market growth.

Prenatal Testing and Newborn Screening Market Size – USD 4,124.3 Million in 2019, Market Growth - CAGR of 12.8%, Market Trends –Rising demand for non-invasive techniques

Get a Free sample of the report : https://www.emergenresearch.com/request-sample/346

The report carefully investigates the present market scenario and the fundamental growth prospects. The report entails an organized database of the Prenatal Testing and Newborn Screening market dynamics that helps market analysts estimate the global market growth rate over the projected timeline. Therefore, the report, published by emergenresearch, is a detail-oriented compilation of the crucial aspects of the Prenatal Testing and Newborn Screening market, including the key players’ product offerings, the wide application range of these products, the major market segments, leading market contenders, their company profiles, pricing strategies, production capacities, revenue generation schemes, technological advancements, and many others.

The prenatal testing and newborn screening market is observing high demand attributed to its increasing application in detecting fetal chromosome defects. Prenatal testing is considered superior to other screening modalities, particularly for trisomy 21 (one of the most prevalent congenital anomalies). Prenatal testing enables individuals to make informed decisions as to whether diagnostic testing should be carried out. Associated fetal chromosomal anomalies typically include the benefit or lack of genetic material that can differ from small segments to small segments of chromosomes to entire chromosomes.

The increasing popularity among pregnant women as an alternative to amniocentesis and awareness of genetic problems in the fetus and newborn babies drives prenatal testing and newborn screening market.

In April 2019, Progenity Inc. made an announcement about the introduction of the Resura Prenatal Test, a non-invasive, personalized prenatal check for monogenetic diseases.

Ultrasonography is projected to observe a significant growth rate in the forecast period, owing to the ability of the ultrasound diagnosis to detect anomalies in the position of the baby and actions within the womb.

The hospital held a substantial market share in 2019 due to the growing introduction of non-invasive prenatal testing, coupled with rapid technological developments in newborn screening, the presence of skilled professionals, and better reimbursement scenario.

North America dominated the market for Prenatal Testing and Newborn Screening in 2019 due to the availability of technologically advanced healthcare research system and developments in whole-genome sequencing.

Key participants include Abbott Laboratories, Bio-Rad Laboratories, Color Genomics, Edinburgh Genomics, Eurofins Scientific, Agilent Technologies, CRISPR, Illumina Inc., Editas Medicine, and Qiagen NV, among others.

Read More: https://www.emergenresearch.com/industry-report/prenatal-testing-and-newborn-screening-market

The Prenatal Testing and Newborn Screening Market Research Report published by emergen research has been formulated by analysis of key business details and extensive geographical spread of the Prenatal Testing and Newborn Screening industry. The study offers comprehensive coverage of the qualitative and quantitative analysis of the Prenatal Testing and Newborn Screening market along with crucial statistical data about the Prenatal Testing and Newborn Screening market. The research study provides historical data from 2017 to 2018 and offers accurate forecast estimation until 2027. The report also profiles established and emerging players of the market, covering the business overview, product portfolio, strategic alliances, and business expansion strategies.

Emergen Research has segmented the global prenatal testing and newborn screening market on the basis of type, test type, technology, instrument, end-users, and region:

Type Outlook (Revenue, USD Billion; 2017-2027)
Prenatal Testing
Newborn Screening
Test Type Outlook (Revenue, USD Billion; 2017-2027)
Non-Invasive
Invasive
Technology Outlook (Revenue, USD Billion; 2017-2027)
Mass Spectrometry
Electrophoresis
Enzyme Immunoassays
DNA Assays
Instrument Outlook (Revenue, USD Billion; 2017-2027)
Ultrasonography
Reagent and Assay Kits
Tandem Quadrupole Detector
Incubator Shaker
Hearing Screen Instruments
End Users Outlook (Revenue, USD Billion; 2017-2027)
Hospitals
Maternity & Specialty Clinics
Diagnostic Centers
Regional Outlook (Revenue, USD Billion; 2017-2027)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
BENELUX
Rest of Europe
Asia Pacific
China
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
MEA
Saudi Arabia
UAE
Rest of MEA
Key Questions Answered in the Report:

What is the growth rate of the Prenatal Testing and Newborn Screening market? What is the anticipated market valuation of Prenatal Testing and Newborn Screening industry by 2027?

What are the key growth driving and restraining factors of the Prenatal Testing and Newborn Screening market?

Who are the prominent players operating in the market? What are the key strategies adopted by these companies?

What are the key opportunities and growth prospects of the Prenatal Testing and Newborn Screening industry over the forecast period?

Which region is expected to show significant growth in the coming years?

Overview of the Prenatal Testing and Newborn Screening Market Report:

Introduction, Product Scope, Market Overview, and Opportunities

Analysis of the Manufacturers with sales, revenue, and price analysis

Comprehensive analysis of the competitive landscape

Extensive profiling of the key competitors along with their business strategies and market size

Regional analysis of the market along with sales, revenue, market share, and global position

Country-wise analysis of the market along with types, applications, and manufacturing

Strategic recommendations to established players as well as new entrants

In-depth analysis of the risks, restraints, and limitations in the Prenatal Testing and Newborn Screening industry

Request customization of the report: https://www.emergenresearch.com/request-for-customization/346

Related Reports:

Spinal Implants and Surgery DevicesMarket: https://www.emergenresearch.com/industry-report/patient-engagement-solutions-market

3D Printing HealthcareMarket: https://www.emergenresearch.com/industry-report/nucleic-acid-isolation-and-purification-market

Non-Invasive Prenatal Testing Market: https://www.emergenresearch.com/industry-report/non-invasive-prenatal-testing-market

Prenatal Testing and Newborn Screening Market: https://www.emergenresearch.com/industry-report/in-vitro-fertilization-market

Blockchain in Healthcare: Https://www.forbes.com/sites/forbestechcouncil/2021/12/07/four-key-medtech-software-development-trends-for-2022/?sh=23e843f420d5

About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs

Eric Lee
Emergen Research
+91 90210 91709
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn